AI-Enabled Medical Imaging Solutions Market Report 2026

AI-Enabled Medical Imaging Solutions Market Overview

• AI-Enabled Medical Imaging Solutions market size has reached to $2.9 billion in 2025 • Expected to grow to $11.23 billion in 2030 at a compound annual growth rate (CAGR) of 31.1% • Growth Driver: AI-Driven Medical Imaging Revolutionizing Early Detection For Chronic Diseases • Market Trend: Revolutionizing Medical Imaging Advancements In AI-Enhanced Image Reconstruction For Precise Diagnosis • North America was the largest region in 2025.

What Is Covered Under AI-Enabled Medical Imaging Solutions Market?

AI-enabled medical imaging solutions encompass a range of technologies that utilize artificial intelligence (AI) in medical imaging technology to increase diagnosis and treatment accuracy, efficiency, and customization. AI-enabled medical imaging solutions improve clinical decision-making and accuracy, alleviate healthcare personnel shortages, and support growing therapeutic applications. The main products of AI-enabled medical imaging solutions are software and hardware. Software is a collection of data, programs, or instructions that run machines and carry out particular functions, and AI-enabled medical imaging systems with software integration show considerable potential for enhancing patient care overall and for increasing diagnostic precision and efficiency. The modalities are categorized into computed tomography (CT), magnetic resonance (MR), x-ray, ultrasound, mammography, multimodality imaging systems, and other modalities integrated with technologies such as deep learning, natural language processing (NLP), computer vision, and other technologies. They are used in applications such as breast imaging, respiratory and pulmonary, neurology, orthopedics, and other applications. Industry verticals include hospital and healthcare providers, patients, pharmaceutical and biotechnology companies, healthcare payers, and others.

What Is The AI-Enabled Medical Imaging Solutions Market Growth Forecast?

The ai-enabled medical imaging solutions market size is expected to see exponential growth in the next few years. It will grow to $11.23 billion in 2030 at a compound annual growth rate (CAGR) of 31.1%. The growth in the forecast period can be attributed to advancements in deep learning and computer vision, growth of personalized diagnostics, rising integration of ai with hospital information systems, increasing healthcare digitization initiatives, expansion of ai-enabled imaging in emerging markets. Major trends in the forecast period include increasing adoption of AI-based diagnostic support tools, rising use of AI-enhanced imaging devices in hospitals, expansion of multimodality imaging systems, growing demand for workflow and management solutions, enhanced accuracy and efficiency in clinical decision-making.

Global AI-Enabled Medical Imaging Solutions Market Segmentation

1) By Product: Software, Hardware 2) By Modality: Computed Tomography (CT), Magnetic Resonance (MR), X-Ray, Ultrasound, Mammography, Multimodality Imaging Systems, Other Modalities 3) By Technology: Deep Learning, Natural Language Processing (NLP), Computer Vision, Other Technologies 4) By Application: Breast Imaging, Respiratory And Pulmonary, Neurology, Orthopedics, Other Applications 5) By Industry Vertical: Hospital And Healthcare Providers, Pharmaceuticals And Biotechnology Companies, Healthcare Payers, Other Industry Verticals Subsegments: 1) By Software: Image Analysis And Interpretation Software, Workflow And Management Solutions, Diagnostic Support Tools 2) By Hardware: AI-Enhanced Imaging Devices, Imaging Sensors And Detectors, Workstations And Displays For Image Processing

What Is The Driver Of The AI-Enabled Medical Imaging Solutions Market?

The increasing prevalence of chronic disorders is expected to propel the growth of the AI-enabled medical imaging solutions market in the coming years. Chronic disorders, or chronic illnesses, are medical conditions that last longer than three months, such as cancer, diabetes, heart disease, arthritis, chronic obstructive pulmonary disease, asthma, and autoimmune diseases. AI-enabled medical imaging speeds up the early diagnosis of chronic illnesses by evaluating complicated imaging data, allowing for faster identification of anomalies and quicker intervention for better patient outcomes. For instance, in September 2023, according to a report published by the World Health Organization (WHO), a Switzerland-based, a specialized UN agency, Noncommunicable diseases (NCDs) claim 41 million lives annually, representing 74% of all global deaths. Of these, 17 million people die from an NCD before the age of 70, with 86% of these premature deaths occurring in low- and middle-income countries. Cardiovascular diseases lead, causing 17.9 million deaths per year, followed by chronic respiratory diseases (4.1 million), cancers (9.3 million), and diabetes (2.0 million, including deaths from kidney disease linked to diabetes). Therefore, the increasing prevalence of chronic disorders is driving the AI-enabled medical imaging solutions industry.

Key Players In The Global AI-Enabled Medical Imaging Solutions Market

Major companies operating in the ai-enabled medical imaging solutions market are Siemens AG, GE HealthCare Technologies, Inc, Koninklijke Philips N.V., Fujifilm Holdings Corporation, Agfa-Gevaert N.V., Carestream Health, Aidoc Medical, Arterys Inc., icometrix, Riverain Technologies, iCAD Inc., Butterfly Network Inc, Subtle Medical, ContextVision AB, DiA Imaging Analysis Ltd, MaxQ AI Ltd, Qview Medical Inc, RADLogics Inc, Ziosoft, SyntheticMR, Beijing Infervision Technology Co. Ltd., NVIDIA Corporation, IBM Corporation, Nuance Communications Inc, EnvoyAI

Global AI-Enabled Medical Imaging Solutions Market Trends and Insights

Major companies operating in the AI-enabled medical imaging solutions market are focusing on AI-enhanced image reconstruction, such as deep learning reconstruction, to offer innovative technology that enables healthcare professionals to diagnose patients while also providing comfort. Deep learning reconstruction (DLR) is a technique used in medical imaging to improve picture quality by employing deep learning algorithms. For instance, in November 2023, Canon Medical Systems USA Inc., a US-based company that offers imaging solutions, launched the Precise IQ Engine. Precise IQ Engine is a high-resolution deep learning reconstruction for magnetic resonance imaging driven by Altivity, a daring new approach to AI innovation that employs smart technologies to achieve a completely new level of quality, insight, and value. PIQE improves matrix size, eliminates noise, and produces clear anatomical pictures, elevating MR imaging to new heights. The PIQE program creates high-spatial-resolution pictures from low-resolution photographs while preserving image quality and reducing ringing effects.

What Are Latest Mergers And Acquisitions In The AI-Enabled Medical Imaging Solutions Market?

In February 2023, GE HealthCare Technologies, Inc., a US-based medical technology company that offers imaging solutions, acquired Caption Health, Inc. for an undisclosed amount. Through the acquisition, GE HealthCare's ultrasound business is boosted by including AI-enabled picture guidance in ultrasound device lineups. Caption Health Inc. is a US-based medical technology company that specializes in AI-enabled ultrasound guidance software.

Regional Outlook

North America was the largest region in the AI-enabled medical imaging market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the AI-Enabled Medical Imaging Solutions Market?

The AI-enabled medical imaging solutions market consists of revenues earned by entities by providing services such as monitoring patient care, computer-aided diagnosis (CAD), image reconstruction, automated tumor detection, and cardiac imaging analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The AI-enabled medical imaging solutions market also includes sales of high-performance computing (HPC) systems, neuroimaging devices, gastrointestinal imaging products, and image segmentation tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the AI-Enabled Medical Imaging Solutions Market Report 2026?

The ai-enabled medical imaging solutions market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the ai-enabled medical imaging solutions industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.